Mithrl, which integrates its proprietary biomedical world model with the R&D systems of pharmaceutical companies, raised a $20M Series A led by Obvious Ventures (Natalie Breymeyer/Axios)
Culture Index
Score Breakdown
Relevance
3/25
Freshness
25/25
Authority
25/20
Brand Signal
6/15
Depth
4/15
5-Axis Cultural Radar
Natalie Breymeyer / Axios : Mithrl, which integrates its proprietary biomedical world model with the R&D systems of pharmaceutical companies, raised a $20M Series A led by Obvious Ventures — Mithrl, an AI infrastructure company for biopharma, raised a $20 million Series A, CEO Vivek Adarsh tells Axios exclusively.
